DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Evogliptin
Evogliptin
Exendin-4 Peptide Analogues As Dual Glp-1/Gip Receptor Agonists
Renato Wilberto Zilli Eficácia Em Longo Prazo Das
Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
Multi-Country Non-Interventional Study on the Effectiveness and Safety of Empagliflozin in Adult Patients with Type 2 Diabetes in Europe and Asia
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
WO 2016/016772 Al 4 February 2016 (04.02.2016) P O P C T
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahr 2020
Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin And
Towards Precision Medicine for Type 2 Diabetes
Pharmaceutical Composition for Preventing Or Treating Diabetes, Containing Zinc Salt, Cyclo-Hispro and Antidiabetic Drug As Active Ingredients
Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating
Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C26457869-01
(12) United States Patent (10) Patent No.: US 9,526,728 B2 Klein Et Al
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Appendix A2: Summary of Evidence from Surveillance (NG28)
VA/Dod CLINICAL PRACTICE GUIDELINE for the MANAGEMENT of CHRONIC KIDNEY DISEASE
Top View
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2018
WO 2017/093465 Al 8 June 2017 (08.06.2017) W P O P C T
Evogliptin Tablets 5 Mg VALERA
Discovery Awaits You at the 81ST Scientific Sessions
Novel Therapeutic Advancements in Type 2 Diabetes
Recommendations of the SEC (Endocrinology & Metabolism)
Development and Validation of Novel UV Spectrophotometric Method for the Determination of Evogliptin Tartarate in Pharmaceutical Dosage Form
Complete Dissertation
PIPELINE PREVIEW: 2016-2017 a SUMMARY of the PHARMACEUTICAL PIPELINE Maria M
Antidiabetic Therapy in the Treatment of NASH
Search Strategy in Pubmed
Recommendations of the SEC (Endocrinology & Metabolism
Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice
Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
Gujarat Technological University Student List for M.Pharm Sem 3 (Regular) Dissertation Phase-1 Exam (Winter 2019) GTU/W19/DP-1/MPH-3213/12167 Date:- 11/11/2019
A101.Full.Pdf
Retrospective, Observational Study on Usage of Evogliptin in T2DM Patients: a Real-World Experience in Indian Patients
Drug Pipelines in the Treatment of NASH
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Overview of Type 2 Diabetes Drugs on the Market
Association Between Use of Sodium-Glucose Cotransporter 2
Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Pathological
WO 2017/095725 Al 8 June 2017 (08.06.2017) W P O P C T
Effects of the Antidiabetic Drugs Evogliptin and Sitagliptin on the Immune Function of CD26/DPP4 in Th1 Cells
Online-Only Supplemental Material
Medicines Regulation
Lowering Drugs on Body Weight in People with Type 1 Diabetes: a Systematic Review and Network Meta-Analysis Protocol
Exercise Testing in Individuals with Diabetes, Practical Considerations for Exercise Physiologists
WO 2016/016770 Al 4 February 2016 (04.02.2016) P O P C T
Identification and Characterization of Antidiabetic And
An Integrated in Silico and in Vitro Assays of Dipeptidyl Peptidase-4 and Α-Glucosidase Inhibition by Stellasterol from Ganoderma Australe
Possibility of Pharmacokinetic Drug Interaction Between a DPP-4 Inhibitor and a SGLT2 Inhibitor